Assignee
FLYNN DANIEL L
US·10 granted patents·15 pending applications·759 citations·filing 2003–2012
Top patents by PatentIndex Score
25 records- 0198US8637672B2Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activitiesFLYNN DANIEL L·Filed 2012·Granted Jan 28, 2014·65 cites·19 claims
- 0298US8461179B1Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseasesFLYNN DANIEL L·Filed 2012·Granted Jun 11, 2013·102 cites·15 claims
- 0398US8163756B2Enzyme modulators and treatmentsFLYNN DANIEL L·Filed 2007·Granted Apr 24, 2012·146 cites·8 claims
- 0497US8921565B2Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activitiesFLYNN DANIEL L·Filed 2012·Granted Dec 30, 2014·62 cites·23 claims
- 0597US8586565B2Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseasesFLYNN DANIEL L·Filed 2010·Granted Nov 19, 2013·62 cites·32 claims
- 0697US8569319B2Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activitiesFLYNN DANIEL L·Filed 2011·Granted Oct 29, 2013·62 cites·23 claims
- 0797US8486951B2Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activitiesFLYNN DANIEL L·Filed 2012·Granted Jul 16, 2013·61 cites·14 claims
- 0897US8278331B2N-acyl ureas exhibiting anti-cancer and anti-proliferative activitiesFLYNN DANIEL L·Filed 2009·Granted Oct 2, 2012·65 cites·7 claims
- 0997US8188113B2Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseasesFLYNN DANIEL L·Filed 2007·Granted May 29, 2012·74 cites·19 claims
- 1096US8143293B2Kinase inhibitors useful for the treatment of myleoprolific diseases and other proliferative diseasesFLYNN DANIEL L·Filed 2008·Granted Mar 27, 2012·60 cites·22 claims
- 1159US2012252849A1Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activitiesFLYNN DANIEL L·Filed 2012·Application pending·0 cites
- 1258US2008187978A1Anti-inflammatory medicamentsFLYNN DANIEL L·Filed 2006·Application pending·0 cites
- 1356US2008248487A1Modulation of protein functionalitiesFLYNN DANIEL L·Filed 2007·Application pending·0 cites
- 1456US2012058985A1Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activitiesFLYNN DANIEL L·Filed 2011·Application pending·0 cites
- 1552US2007078121A1Enzyme modulators and treatmentsFLYNN DANIEL L·Filed 2005·Application pending·0 cites
- 1651US2008045706A1Anti-inflammatory medicamentsFLYNN DANIEL L·Filed 2005·Application pending·0 cites
- 1751US2008045531A1Anti-inflammatory medicamentsFLYNN DANIEL L·Filed 2005·Application pending·0 cites
- 1849US2012289540A1Kinase inhibitors useful for the treatment of proliferative diseasesFLYNN DANIEL L·Filed 2012·Application pending·0 cites
- 1949US2008248548A1Modulation of protein functionalitiesFLYNN DANIEL L·Filed 2007·Application pending·0 cites
- 2046US2011118271A1Kinase Inhibitors Useful For The Treatment Of Proliferative DiseasesFLYNN DANIEL L·Filed 2011·Application pending·0 cites
- 2146US2007191336A1Anti-inflammatory medicamentsFLYNN DANIEL L·Filed 2004·Application pending·0 cites
- 2244US2008220497A1Modulation of protein functionalitiesFLYNN DANIEL L·Filed 2005·Application pending·0 cites
- 2343US2004171075A1Modulation of protein functionalitiesFLYNN DANIEL L·Filed 2003·Application pending·0 cites
- 2440US2012225057A1Methods and compositions for the treatment of myeloproliferative diseases and other proliferative diseasesFLYNN DANIEL L·Filed 2011·Application pending·0 cites
- 2537US2011189167A1Methods and Compositions for the Treatment of Myeloproliferative Diseases and other Proliferative DiseasesFLYNN DANIEL L·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when FLYNN DANIEL L files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →